Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
US Army
Chinese Patent Office

Generated: February 17, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,177,263

« Back to Dashboard

Summary for Patent: 4,177,263
Title: Anti-animal tumor method
Abstract:Malignant tumors in animals are treated by parenterally administering to an affected animal a solution containing a complex compound of platinum in an amount effective to cause regression of the tumor.
Inventor(s): Rosenberg; Barnett (Holt, MI), VanCamp; Loretta (East Lansing, MI), Krigas; Thomas (Okemos, MI)
Assignee: Research Corporation (New York, NY)
Application Number:05/754,512
Patent Claims: 1. A method of treating animal malignant tumor cells sensitive to cis-Pt(II)(NH.sub.3).sub.2 Cl.sub.2 in animals which comprises parenterally administering to an animal afflicted with said tumor cells a solution containing cis-Pt(II)(NH.sub.3).sub.2 Cl.sub.2 in an amount sufficient to cause regression of the animal tumor cells.

2. A method according to claim 1 wherein the chloroplatinumammine is administered in multiple doses.

3. A method according to claim 1 wherein the chloroplatinumammine is administered in a single dose.

4. A method according to claim 1 wherein the chloroplatinumammine is administered in a saline salt-containing buffer solution.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Queensland Health
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.